Psybio logo.png
Miami University Researchers Collaborate with PsyBio Therapeutics to Biosynthetically Produce Psilocybin, the Psychedelic Ingredient in Magic Mushrooms, and Other Psychoactive Drug Candidates to Treat Mental Health Challenges
May 22, 2020 08:30 ET | PsyBio Therapeutics Inc.
OXFORD, Ohio, May 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Miami University in Oxford, Ohio, and PsyBio Therapeutics Inc. (“PsyBio”) are collaborating to develop a new and...
Biotii GN.png
Gratian Schindler joins Biotii Technologies as Advisor
September 24, 2019 14:31 ET | Biotii Technologies Corp.
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Biotii Technologies Corp. (the “Company” or "Biotii") is pleased to announce that the Company has entered into an advisory agreement...
NetworkNewsWire Announces Publication Discussing the Production of Quality Cannabinoids with Therapeutic Potential
December 13, 2017 08:30 ET | NetworkNewsWire
NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial...